Drawing on evidence from other autoimmune and chronic pain conditions—as well as current insights into JAK/STAT signaling and mast cell involvement in endometriosis—we propose that evaluating these agents represents a promising and necessary direction for future research and therapeutic development. This evidence concerns the gene SOAT1 and endometriosis.